GO:0008412 4-hydroxybenzoate polyprenyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008412 describes the enzymatic activity that attaches a polyprenyl diphosphate tail to 4-hydroxybenzoate, producing a 4-hydroxy-3-all-trans-polyprenylbenzoate and releasing diphosphate.
• This activity is the committed step in ubiquinone (coenzyme Q) biosynthesis and is encoded by COQ2 in humans and yeast, and by orthologs such as OsPPT1 in rice.
• The enzyme is membrane-associated and requires divalent metal ions and detergent solubilization for in vitro activity.
• Loss of 4-hydroxybenzoate polyprenyltransferase activity impairs mitochondrial respiration and has been linked to CoQ10 deficiency and mitochondrial disease.
• In malaria parasites, inhibition of this activity by 4-nitrobenzoate enhances the efficacy of atovaquone, highlighting it as a drug target.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect the catalytic residues, substrate specificity and physiological roles of this enzyme.
Description
4-hydroxybenzoate polyprenyltransferase activity (GO:0008412) catalyzes the transfer of an all-trans-polyprenyl diphosphate to 4-hydroxybenzoate, forming a 4-hydroxy-3-all-trans-polyprenylbenzoate and diphosphate. This reaction is the first committed step in the biosynthesis of ubiquinone (coenzyme Q), a lipid-soluble electron carrier in the mitochondrial respiratory chain. Because ubiquinone is essential for oxidative phosphorylation and as an antioxidant, the enzyme that performs this step is central to mitochondrial bioenergetics and cellular redox homeostasis. Researchers study GO:0008412 to understand mitochondrial disease, to develop antiparasitic and anticancer agents, and to engineer metabolic pathways in microbes and plants. The activity has been characterized biochemically in Escherichia coli, rat liver, yeast and plants, revealing a membrane-bound enzyme that uses polyprenyl diphosphate substrates of varying chain length. In this article, we integrate the QuickGO definition with verified literature to provide a research-grade overview of the mechanism, genes, regulation, disease links and experimental models for GO:0008412.
4-hydroxybenzoate polyprenyltransferase activity At A Glance
| GO ID | GO:0008412 |
|---|---|
| GO term | 4-hydroxybenzoate polyprenyltransferase activity |
| Ontology | molecular_function |
| Synonym | 4-HB polyprenyltransferase activity; 4-hydroxybenzoate nonaprenyltransferase activity; para-hydroxybenzoate-polyprenyl diphosphate transferase activity; para-hydroxybenzoate:polyprenyltransferase activity; para-hydroxybenzoate transferase activity; PHB polyprenyl diphosphate transferase activity |
| Definition | Catalysis of the reaction: 4-hydroxybenzoate + an all-trans-polyprenyl diphosphate = a 4-hydroxy-3-all-trans-polyprenylbenzoate + diphosphate. |
| Major function | Committed step in ubiquinone (coenzyme Q) biosynthesis; transfers a polyprenyl chain to 4-hydroxybenzoate. |
| Cellular location | Membrane-associated, typically mitochondrial inner membrane or bacterial plasma membrane. |
| Representative genes | COQ2 (human, yeast), OsPPT1 (rice), ubiA (E. coli). |
| Cofactors | Divalent metal ions (e.g., Mg2+ or Mn2+) are required for activity. |
What Is GO:0008412?
In our own words, GO:0008412 is a molecular function that enables an enzyme to catalyze the reaction: 4-hydroxybenzoate + an all-trans-polyprenyl diphosphate = a 4-hydroxy-3-all-trans-polyprenylbenzoate + diphosphate. The enzyme binds 4-hydroxybenzoate and a polyprenyl diphosphate (such as nonaprenyl diphosphate in bacteria or decaprenyl diphosphate in humans) and forms a carbon-carbon bond between the aromatic ring and the polyprenyl chain, releasing diphosphate. This activity is synonymous with 4-HB polyprenyltransferase, para-hydroxybenzoate:polyprenyltransferase and PHB polyprenyl diphosphate transferase.
Why Is 4-hydroxybenzoate polyprenyltransferase activity Important in Cell Biology?
GO:0008412 is important because it governs the first committed step of ubiquinone biosynthesis, a pathway essential for mitochondrial respiration, antioxidant defense and cellular metabolism. Dysregulation of this activity leads to coenzyme Q10 deficiency, which manifests as mitochondrial disease, and the enzyme is a validated drug target in malaria parasites. Understanding its mechanism and regulation is therefore critical for both fundamental cell biology and therapeutic development.
• Catalyzes the committed step in ubiquinone (coenzyme Q) biosynthesis, essential for mitochondrial electron transport.
• Mutations in COQ2, the gene encoding this activity, cause primary coenzyme Q10 deficiency and mitochondrial disease.
• The enzyme is a target for antiparasitic drugs; 4-nitrobenzoate inhibits it in malaria parasites and enhances atovaquone efficacy.
• Its activity is required for oxidative stress resistance because ubiquinone is a lipid-soluble antioxidant.
• Plant orthologs such as OsPPT1 are important for growth and stress responses in crops.
• The enzyme is membrane-bound and requires detergents for solubilization, making it a model for studying membrane protein catalysis.
• It accepts polyprenyl diphosphates of different chain lengths, providing a system to study substrate specificity.
• Its activity can be stimulated by cytosolic protein factors and detergents, revealing regulatory mechanisms.
• Defects in this activity impair mitochondrial development in yeast.
• It is a potential target for herbicides and antimicrobials due to its essential role in ubiquinone biosynthesis.
Molecular Mechanism of 4-hydroxybenzoate polyprenyltransferase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs two molecules, 4-hydroxybenzoate and a long lipid tail, and joins them together.
The enzyme binds 4-hydroxybenzoate and an all-trans-polyprenyl diphosphate in a membrane environment. Catalysis proceeds via a nucleophilic attack of the aromatic ring on the polyprenyl diphosphate, forming a new carbon-carbon bond and releasing diphosphate. The reaction is metal-dependent, with divalent cations such as Mg2+ required for activity.
Polyprenyl Chain Length Specificity
In simple terms: Different organisms use different lengths of the lipid tail, and the enzyme selects the right one.
The enzyme from E. coli prefers nonaprenyl diphosphate (nine isoprene units), while the human enzyme uses decaprenyl diphosphate (ten units). Plant OsPPT1 also exhibits specificity for its native polyprenyl diphosphate. This specificity is determined by the enzyme's active site architecture and is critical for producing the correct ubiquinone species.
Membrane Association and Solubilization
In simple terms: The enzyme sits in the membrane, and scientists need detergents to study it in a test tube.
4-hydroxybenzoate polyprenyltransferase is an integral membrane protein associated with the mitochondrial inner membrane or bacterial plasma membrane. Detergents such as sodium cholate and CHAPS stimulate its activity in vitro, likely by solubilizing the enzyme and its lipid substrates. A cytosolic protein factor has also been shown to stimulate activity, possibly by facilitating polyprenyl pyrophosphate transport.
Role in Ubiquinone Biosynthesis
In simple terms: This enzyme makes the first unique intermediate that eventually becomes coenzyme Q.
The product of GO:0008412, 4-hydroxy-3-all-trans-polyprenylbenzoate, is subsequently modified by methylation, decarboxylation and hydroxylation to yield ubiquinone. This step is rate-limiting and committed, making it a key regulatory point in the pathway. In yeast, the activity is linked to mitochondrial development, and its loss impairs respiration.
Inhibition and Pharmacological Targeting
In simple terms: Certain chemicals can block this enzyme, which can kill parasites or sensitize them to other drugs.
4-nitrobenzoate inhibits 4-hydroxybenzoate polyprenyltransferase in malaria parasites and enhances the efficacy of atovaquone, a mitochondrial electron transport inhibitor. This suggests that the enzyme is a promising target for combination therapy. In bacteria, the enzyme is also a target for antimicrobial discovery.
Key Genes Involved in GO:0008412 4-hydroxybenzoate polyprenyltransferase activity
The genes encoding 4-hydroxybenzoate polyprenyltransferase activity are conserved across bacteria, yeast, plants and humans, with COQ2 being the best-characterized human and yeast gene.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COQ2 (human) | Encodes para-hydroxybenzoate:polyprenyltransferase, catalyzing the committed step in CoQ10 biosynthesis | Mutations cause CoQ10 deficiency and mitochondrial disease; target for drug development |
| COQ2 (yeast) | Ortholog of human COQ2; required for ubiquinone biosynthesis and mitochondrial development | Model organism for studying enzyme function and mitochondrial respiration |
| OsPPT1 (rice) | p-hydroxybenzoate polyprenyltransferase involved in ubiquinone biosynthesis | Plant model for studying ubiquinone function in growth and stress responses |
| ubiA (E. coli) | 4-hydroxybenzoate polyprenyltransferase; uses nonaprenyl diphosphate | Bacterial model for enzyme kinetics and inhibitor screening |
| COQ1 | Polyprenyl diphosphate synthase, provides the polyprenyl diphosphate substrate for COQ2 | Upstream enzyme in the pathway; co-expression studies with COQ2 |
| COQ3 | O-methyltransferase in ubiquinone biosynthesis, acts after COQ2 | Downstream enzyme; used to study pathway flux |
| COQ4 | Required for ubiquinone biosynthesis, may stabilize the COQ complex | Potential interaction partner of COQ2 |
| COQ5 | C-methyltransferase in ubiquinone biosynthesis | Downstream enzyme; pathway analysis |
| COQ6 | Monooxygenase in ubiquinone biosynthesis | Downstream enzyme; disease relevance |
| COQ7 | Hydroxylase in ubiquinone biosynthesis | Downstream enzyme; regulation of CoQ synthesis |
| COQ8 | Putative kinase involved in ubiquinone biosynthesis regulation | Regulatory component; potential target |
| COQ9 | Lipid-binding protein in ubiquinone biosynthesis | May interact with COQ2 |
| COQ10 | Protein required for ubiquinone biosynthesis, function unclear | Potential chaperone for COQ2 |
| PDSS1 | Decaprenyl diphosphate synthase subunit 1, provides substrate for COQ2 | Upstream enzyme; co-expression with COQ2 |
| PDSS2 | Decaprenyl diphosphate synthase subunit 2, provides substrate for COQ2 | Upstream enzyme; disease relevance |
| UbiA (plant) | Homolog of bacterial UbiA, involved in ubiquinone biosynthesis | Plant model for enzyme function |
| PPT1 (plant) | Polyprenyltransferase involved in ubiquinone biosynthesis | Plant model for stress responses |
How Is 4-hydroxybenzoate polyprenyltransferase activity Regulated?
The activity of 4-hydroxybenzoate polyprenyltransferase is regulated at multiple levels. In yeast, its expression and activity are linked to mitochondrial development, with higher activity observed during respiratory growth. The enzyme requires divalent metal ions for catalysis, and its activity can be stimulated by detergents and a cytosolic protein factor that may facilitate substrate transport. In plants, OsPPT1 expression is regulated in response to developmental and environmental cues. In humans, COQ2 expression is coordinated with other ubiquinone biosynthesis genes, and mutations in COQ2 lead to CoQ10 deficiency. Pharmacological inhibition by 4-nitrobenzoate demonstrates that the enzyme can be targeted, and its activity is also influenced by the availability of polyprenyl diphosphate substrates produced by COQ1 and PDSS1/PDSS2.
4-hydroxybenzoate polyprenyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COQ2 | Primary coenzyme Q10 deficiency; mitochondrial disease | COQ2 knockout human cells; patient fibroblasts |
| COQ2 | Malaria parasite ubiquinone biosynthesis; drug target | Plasmodium falciparum culture; mouse malaria model |
| COQ2 | Mitochondrial myopathy and encephalopathy | COQ2 mutant yeast; induced pluripotent stem cells |
| COQ2 | Neurodegeneration associated with CoQ10 deficiency | Neuronal cell models with COQ2 knockout |
| OsPPT1 | Plant growth and stress response | Rice knockout and overexpression lines |
Primary Coenzyme Q10 Deficiency
Mutations in COQ2, the gene encoding 4-hydroxybenzoate polyprenyltransferase activity, cause primary coenzyme Q10 deficiency, a rare mitochondrial disorder characterized by encephalopathy, nephropathy, and cardiomyopathy. Loss of enzyme activity reduces ubiquinone levels, impairing mitochondrial respiration and increasing oxidative stress. Experimental models include COQ2 knockout cells and patient-derived fibroblasts, which show reduced CoQ10 and respiratory chain defects.
Malaria and Parasitic Infections
In malaria parasites, 4-hydroxybenzoate polyprenyltransferase is essential for ubiquinone biosynthesis, and its inhibition by 4-nitrobenzoate enhances the efficacy of atovaquone, a drug that targets the parasite's mitochondrial electron transport chain. This highlights the enzyme as a potential drug target for combination therapy. Experimental models include Plasmodium falciparum cultures and mouse models of malaria.
Mitochondrial Myopathies and Neurodegeneration
Defects in ubiquinone biosynthesis, including reduced 4-hydroxybenzoate polyprenyltransferase activity, have been associated with mitochondrial myopathies and neurodegenerative conditions. CoQ10 supplementation is a common therapy, but its efficacy depends on the specific genetic defect. Research models include COQ2 mutant yeast and human cell lines.
From 4-hydroxybenzoate polyprenyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of COQ2? | Point mutations in COQ2 active site residues in human cells or yeast |
| How does loss of COQ2 affect mitochondrial respiration? | COQ2 knockout in HeLa or HEK293 cells |
| Can COQ2 be targeted for antiparasitic therapy? | Plasmodium falciparum knockout or knockdown |
| What is the role of COQ2 in CoQ10 biosynthesis? | Knock-in of tagged COQ2 for localization and interaction studies |
| How does overexpression of COQ2 affect ubiquinone levels? | COQ2 overexpression in mammalian cells or yeast |
| What is the substrate specificity of plant PPT1? | OsPPT1 knockout and overexpression in rice |
How to Study the 4-hydroxybenzoate polyprenyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled enzyme assay | Catalytic activity of 4-hydroxybenzoate polyprenyltransferase | Kinetic analysis and inhibitor screening |
| HPLC/LC-MS | Levels of ubiquinone and intermediates | Metabolic profiling in cells and tissues |
| Western blot | Protein expression of COQ2 | Validation of knockout or overexpression |
| Fluorescence microscopy | Subcellular localization of tagged COQ2 | Mitochondrial targeting studies |
| Yeast complementation | Rescue of respiratory growth defect | Functional testing of COQ2 variants |
| CRISPR knockout | Loss of gene function | Phenotypic analysis and disease modeling |
| RNA-seq | Transcriptional changes upon COQ2 perturbation | Pathway analysis and biomarker discovery |
| Co-immunoprecipitation | Protein-protein interactions of COQ2 | Identification of complex components |
Enzymatic Assays
4-hydroxybenzoate polyprenyltransferase activity is typically measured using radiolabeled 4-hydroxybenzoate and polyprenyl diphosphate, followed by extraction and thin-layer chromatography or HPLC to detect the product. Detergents such as CHAPS or sodium cholate are often included to stimulate activity. These assays are used to determine kinetic parameters and to screen inhibitors.
Genetic Knockout and Complementation
Knockout of COQ2 in yeast or human cells results in loss of ubiquinone and respiratory deficiency, which can be rescued by expressing wild-type or mutant COQ2. This approach is used to test the pathogenicity of patient mutations and to dissect structure-function relationships.
Subcellular Localization and Imaging
Fluorescent tagging of COQ2 (e.g., GFP) followed by confocal microscopy reveals its mitochondrial localization. Co-localization with mitochondrial markers confirms its presence in the inner membrane. These methods are used to study protein trafficking and assembly.
Metabolite Profiling
Mass spectrometry-based lipidomics can quantify ubiquinone and its intermediates, including 4-hydroxy-3-polyprenylbenzoate, in cells and tissues. This method is used to assess pathway flux and the impact of genetic or pharmacological perturbations.
How CRISPR Can Be Used to Study GO:0008412 4-hydroxybenzoate polyprenyltransferase activity
Knockout
CRISPR knockout of COQ2 in human cell lines (e.g., HEK293, HeLa) abolishes 4-hydroxybenzoate polyprenyltransferase activity, leading to reduced ubiquinone levels and impaired mitochondrial respiration. These models are used to study the consequences of CoQ10 deficiency and to test rescue by wild-type or mutant COQ2. In Plasmodium, knockout of the orthologous gene reduces parasite growth and increases sensitivity to atovaquone.
Point Mutation
CRISPR-mediated point mutations can introduce patient-specific missense mutations into COQ2 to assess their impact on enzyme activity and stability. For example, mutations in the active site or substrate-binding pocket can be generated to dissect catalytic residues. These models help establish genotype-phenotype correlations in CoQ10 deficiency.
Knock-in
Knock-in of epitope-tagged COQ2 (e.g., FLAG or GFP) allows for affinity purification and interaction studies. Tagged knock-in cell lines can be used to determine the composition of the ubiquinone biosynthesis complex and to monitor protein localization in real time. This approach is valuable for understanding how COQ2 interacts with other COQ proteins.
Overexpression
Overexpression of COQ2 in mammalian cells or yeast increases 4-hydroxybenzoate polyprenyltransferase activity and can elevate ubiquinone levels, provided substrates are available. Overexpression models are used to study the effects of increased CoQ10 on oxidative stress resistance and mitochondrial function. In plants, overexpression of OsPPT1 may enhance stress tolerance.
How EDITGENE Supports 4-hydroxybenzoate polyprenyltransferase activity Research
Researchers studying 4-hydroxybenzoate polyprenyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in ubiquinone biosynthesis, mitochondrial function or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of GO:0008412-related genes.
Contact EDITGENE today to design your custom CRISPR model for 4-hydroxybenzoate polyprenyltransferase activity research.
Frequently Asked Questions About 4-hydroxybenzoate polyprenyltransferase activity
What is 4-hydroxybenzoate polyprenyltransferase activity?
It is the enzymatic activity (GO:0008412) that transfers a polyprenyl diphosphate to 4-hydroxybenzoate, forming a 4-hydroxy-3-all-trans-polyprenylbenzoate and diphosphate, a key step in ubiquinone biosynthesis.
What genes are involved in 4-hydroxybenzoate polyprenyltransferase activity?
The main gene is COQ2 in humans and yeast, with orthologs such as ubiA in E. coli and OsPPT1 in rice.
What is the role of COQ2 in ubiquinone biosynthesis?
COQ2 encodes the enzyme that catalyzes the committed step in ubiquinone biosynthesis, producing the polyprenylated intermediate that is further modified to coenzyme Q.
How is 4-hydroxybenzoate polyprenyltransferase activity measured?
It is typically assayed using radiolabeled 4-hydroxybenzoate and polyprenyl diphosphate, followed by chromatographic separation of the product.
What diseases are associated with defects in this activity?
Mutations in COQ2 cause primary coenzyme Q10 deficiency, a mitochondrial disorder with encephalopathy, nephropathy and cardiomyopathy.
Can 4-hydroxybenzoate polyprenyltransferase be targeted for malaria treatment?
Yes, 4-nitrobenzoate inhibits the enzyme in malaria parasites and enhances atovaquone efficacy, suggesting a potential combination therapy.
What are the substrates of 4-hydroxybenzoate polyprenyltransferase?
The substrates are 4-hydroxybenzoate and an all-trans-polyprenyl diphosphate, such as nonaprenyl diphosphate in bacteria or decaprenyl diphosphate in humans.
How is 4-hydroxybenzoate polyprenyltransferase regulated?
Its activity is regulated by substrate availability, divalent metal ions, detergents and a cytosolic protein factor; expression is linked to mitochondrial development.
What model organisms are used to study this enzyme?
Escherichia coli, Saccharomyces cerevisiae, Oryza sativa and human cell lines are commonly used.
What CRISPR models are available for studying 4-hydroxybenzoate polyprenyltransferase?
Knockout, point mutation, knock-in and overexpression models can be generated in various cell types to study enzyme function and disease mechanisms.
Conclusion
4-hydroxybenzoate polyprenyltransferase activity (GO:0008412) is a fundamental enzymatic activity in ubiquinone biosynthesis, with critical roles in mitochondrial function, oxidative stress resistance and human disease. Its best-characterized gene, COQ2, is linked to primary coenzyme Q10 deficiency and is a target for antiparasitic therapy. Continued research using CRISPR-based models will further elucidate its mechanism, regulation and therapeutic potential. EDITGENE offers comprehensive services to support these investigations.
References
- 1. Verdaguer IB et al.. 2026. 4-nitrobenzoate inhibits 4-hydroxybenzoate polyprenyltransferase in malaria parasites and enhances atovaquone efficacy.. FEBS Lett 600(2):251-266 PMID: 41088842
- 2. Melzer M et al.. 1994. Characterization of polyprenyldiphosphate: 4-hydroxybenzoate polyprenyltransferase from Escherichia coli.. Biochim Biophys Acta 1212(1):93-102 PMID: 8155731
- 3. Gupta A et al.. 1985. 4-Hydroxybenzoate polyprenyltransferase from rat liver.. Methods Enzymol 110:327-34 PMID: 4021818
- 4. Casey J et al.. 1977. Polyprenylpyrophosphate:4-hydroxybenzoate-polyprenyltransferase activity in yeast. Relationship to mitochondrial development.. Biochim Biophys Acta 489(2):343-7 PMID: 922035
- 5. Burón MI et al.. 2006. Stimulation of polyprenyl 4-hydroxybenzoate transferase activity by sodium cholate and 3-[(cholamidopropyl)dimethylammonio]-1-propanesulfonate.. Anal Biochem 353(1):15-21 PMID: 16643834
- 6. Ashby MN et al.. 1992. COQ2 is a candidate for the structural gene encoding para-hydroxybenzoate:polyprenyltransferase.. J Biol Chem 267(6):4128-36 PMID: 1740455
- 7. Ohara K et al.. 2006. Functional characterization of OsPPT1, which encodes p-hydroxybenzoate polyprenyltransferase involved in ubiquinone biosynthesis in Oryza sativa.. Plant Cell Physiol 47(5):581-90 PMID: 16501255
- 8. Gupta A et al.. 1984. Stimulation of rat liver 4-hydroxybenzoate: polyprenyl transferase activity by a cytosolic protein factor; evidence for a polyprenyl pyrophosphate transport protein.. Biochem Biophys Res Commun 119(3):1109-15 PMID: 6712669
